Best minimally modified antisense oligonucleotides according to cell nuclease activity

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 3, 2001, Pages 129-136

  Djavanbakht Samani, Taraneh ^a   Jolles, Béatrice ^a   Laigle, Alain ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENDONUCLEASE; EXONUCLEASE; PHOSPHOROTHIOIC ACID DERIVATIVE; PYRIMIDINE; RIBONUCLEASE H;

ARTICLE; DEGRADATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE;

BASE SEQUENCE; BINDING SITES; CPG ISLANDS; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDONUCLEASES; EXONUCLEASES; GENES, MDR; HUMANS; K562 CELLS; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;

EID: 0034958601     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001300338654     Document Type: Article

References (37)

1. Perspectives in antisense therapeutics
2. Antisense therapeutics
3. Inhibition of expression of the multidrug resistance-associated P-glycoprotein by phosphorothioate and 5′ cholesterol-conjugated phosphorothioate antisense oligonucleotides
4. Reversal of multidrug resistance in vitro by phosphorothioate oligonucleotides and ribozymes
5. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism
6. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins
7. Therapeutic applications of oligonucleotides
8. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligonucleotides
9. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules
10. Expression of a multidrug-resistance gene in human tumors and tissues
11. Zwischenmolekular energiewanderung und fluorescenz
12. Most compact hairpin-turn structure exerted by a short DNA fragment, D(GCGAAGC) in solution - An extraordinarily stable structure resistant to nucleases and heat
13. Extraordinarily stable mini-hairpins - Electrophoretical and thermal properties of the various sequence variants of d(GCGAAAGC) and their effect on DNA sequencing
14. Opening of the extraordinarily stable mini-hairpin d(GCGAAGC)
15. A new vector using the multidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells
16. A novel method to stabilise antisense oligonucleotides against exonuclease degradation
17. Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type I immediate-early mRNA
18. Spectral shape modifications of anthracyclines bound to cell nuclei: A microspectrofluorometric study
19. P-glycoprotein and resistance to anticancer drugs
20. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides
21. Physico-chemical and biological properties of antisense phosphodiester oligonucleotides with various secondary structures
22. Study of antisense oligonucleotide phosphorothioates containing segments of 2′-O-methyloligoribonucleotides
23. Donor-acceptor distance distributions in a double-labeled fluorescent oligonucleotide both as a single strand and in duplexes
24. Nuclease stability as dominant factor in the antiviral activity of oligonucleotides directed against HSV-1 IE110
25. Minimally modified oligonucleotides - Combination of end-capping and pyrimidine protection
26. Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkages
27. Fluorescence resonance energy transfer analysis of the degradation of an oligonucleotide protected by a very stable hairpin
28. The role of MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo
29. Modified deoxyoligonucleotides stable to exonuclease degradation in serum
30. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
31. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
32. Microspectrofluorimetric study of the kinetics of cellular uptake and metabolization of benzo(a)pyrene in human T 47D mammary tumor cells: Evidence for cytochrome p450 induction
33. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption
34. Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression
35. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides
36. GNA trinucleotide loop sequences producing extraordinarily stable DNA minihairpins
37. Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects